Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|July 11, 2017
Targeting of Antithrombin in Hemophilia A or B with RNAi TherapyK John Pasi, Savita Rangarajan, Pencho Georgiev, et al.
Thrombosis and Haemostasis|May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A PatientsLaura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Blood|June 23, 2016
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia AJohnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, et al.
Blood|November 15, 2013
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia AJohnny Mahlangu, Jerry S Powell, Margaret V Ragni, et al.
The New England Journal of Medicine|June 11, 2025
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia BUlrike M Reiss, Andrew M Davidoff, Edward G D Tuddenham, et al.
The New England Journal of Medicine|November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia BAmit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
The New England Journal of Medicine|December 14, 2011
Adenovirus-associated virus vector-mediated gene transfer in hemophilia BAmit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, et al.
Journal of Clinical Medicine|September 28, 2023
Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept TrialPratima Chowdary, Banwari Agarwal, Maria Rita Peralta, et al.
Pageof 13